Opendata, web and dolomites

ABT

AXVIRIUM BIOACTIVE TECNOLOGY_ The first medical device able to eliminate the fluids biological hazard

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ABT project word cloud

Explore the words cloud of the ABT project. It provides you a very rough idea of what is the project "ABT" about.

fluid    accidents    virus    molecules    almost    fluids    disposal    hepatitis    nosocomial    hazardous    saving    axivirium    device    bioactive    39    occupational    eur    200    cross    skilled    18    2022    axvirium    estimate    medical    segments    ip    anticipated    community    caused    waste    market    natural    incorrect    degradation    organisation    improper    proper    economic    survey    completely    nearly    tons    reducing    investigation    valuation    biological    global    commercial    identification    world    barriers    cut    direct    customer    innovative    care    hiv    66    14    21    billion    posing    accounted    reg    rnases    biomedical    infectious    worldwide    16    sterilize    amongst    100    20    ing    23    cagr    imply    competitors    impacts    time    decreasing       positive    adantium    7000    plus    infection    abt    efficiency    tecnology    risks    annually    2018    feasibility    strategy    validation    million    environment    reduce    health    employees    industry    hire    diseases    healthcare    facilities    solution    individuals    day    structures    validate   

Project "ABT" data sheet

The following table provides information about the project.

Coordinator
ENPROJECT MEDICALI SRL 

Organization address
address: VIALE CARLO FAINA 30
city: MARSCIANO
postcode: 6055
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website https://www.enprojectmedicali.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-02-01   to  2019-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ENPROJECT MEDICALI SRL IT (MARSCIANO) coordinator 50˙000.00

Map

 Project objective

The aim of the project is to validate the technical and economic feasibility of AXVIRIUM BIOACTIVE TECNOLOGY (ABT) an innovative biomedical device, based on the Adantium® Plus and Axivirium BIOACTIVE® molecules, enable to cut biological risks, improve efficiency and reduce cost of health care biomedical fluids disposal. Medical waste is posing a growing problem worldwide resulting in nearly 7000 tons every day of infectious /hazardous medical waste and 10 billion euro annually in disposal cost across the European health care industry. According to the World Health Organisation (WHO), incorrect and improper management of healthcare biological fluids can have direct impacts on the community, individuals working in health care facilities, and the natural environment. It estimated that at world level accidents caused by not proper biological risks management accounted for 66,000 cases of infection with the hepatitis B virus, 16,000 cases of infection with hepatitis C virus and 200 to 5,000 cases of HIV infection amongst the personnel of health-care facilities. Compared to competitors ABT is the unique solution able to reach 100% degradation of RNases almost in real time and completely sterilize biological fluids. This imply saving operational cost up to 20%, decreasing occupational diseases by 39% and reducing cross- nosocomial infection by 14%. In 2018, the valuation of the global fluid management market was EUR 10 billion and is anticipated to reach EUR 18 billion by 2022, at a positive CAGR of 4.8% in the next three years. The estimated market potential for ABT is about 21 million euro and we estimate to hire 23 high skilled employees. The feasibility study comprises an investigation of market structures, segments and barriers, a customer survey and product validation, the identification of key commercial partners and the development of an IP strategy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

GREEN WHS (2019)

NATURE FRIENDLY WATER HYDRAULIC STEERING SYSTEM

Read More  

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

TuneFork (2018)

Mobile technology that brings personalized audio into your life

Read More